Structured evidence table for Quercetin Immune Support Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Quercetin Immune Support Randomized Trial | For a while now, herbal ingredients have been incorporated into oral care products, primarily in South Asian countries, to help people with gingivitis and maintain improved oral hygiene []. | 2 | Muacevic Alexander (2026) | Quercetin as a Natural Adjunct in Managing Plaque and Gingivitis in Adults: A Randomized Controlled Trial |
| Quercetin Immune Support Randomized Trial | 8 9 10 11 12 13 Streptococcus mutans Pseudomonas aeruginosa Bacillus subtilis Enterococcus faecalis Gingivitis affects a large number of people worldwide and is regarded as an initial stage of periodontitis, which is a result of pathological alterations brought by the accumulated tooth surface plaque or biofilm []. | 2 | Muacevic Alexander (2026) | Quercetin as a Natural Adjunct in Managing Plaque and Gingivitis in Adults: A Randomized Controlled Trial |
| Quercetin Immune Support Randomized Trial | (2019) demonstrated quercetin's anti-biofilm effectiveness against, and the researchers found that at a dose of 500 µg/mL, quercetin totally inhibited (100%) all of the isolates tested in the research []. | 2 | Muacevic Alexander (2026) | Quercetin as a Natural Adjunct in Managing Plaque and Gingivitis in Adults: A Randomized Controlled Trial |
| Quercetin Immune Support Randomized Trial | 1 Antimicrobial mouthwashes serve as a crucial adjunct to prevent oral diseases, particularly in the prevention and management of periodontal disease, by effectively reducing dental plaque biofilm. | 2 | Muacevic Alexander (2026) | Quercetin as a Natural Adjunct in Managing Plaque and Gingivitis in Adults: A Randomized Controlled Trial |
| Quercetin Immune Support Randomized Trial | 1 Infection during pregnancy severely threatens the health of both the mother and fetus during the perinatal period, and acts as a high-risk pathogenic factor for multiple pregnancy-related diseases. | 3 | Shi Jiena (2026) | Research progress of quercetin in infection at the maternal-fetal interface |
| Quercetin Immune Support Randomized Trial | Some antibiotics have a certain risk of teratogenicity and need to be avoided or used with caution (). | 3 | Shi Jiena (2026) | Research progress of quercetin in infection at the maternal-fetal interface |
| Quercetin Immune Support Randomized Trial | In reproductive medicine, increasing evidence indicates that quercetin can regulate immune function at the maternal-fetal interface, reduce abortion rates, and improve pregnancy outcomes (–). | 3 | Shi Jiena (2026) | Research progress of quercetin in infection at the maternal-fetal interface |
| Quercetin Immune Support Randomized Trial | More critically, vertical mother-to-fetus transmission of pathogenic microorganisms can induce infection in the fetus and neonate, leading to neonatal birth defects (). | 3 | Shi Jiena (2026) | Research progress of quercetin in infection at the maternal-fetal interface |
Source documents